Fermentation tech could account for 4% of global protein production by 2050, but it needs $250B of investment to meet the ...

BRITISH pharmaceutical giant AstraZeneca has struck a deal of up to US$1bn to acquire a biotech company specialising in cell therapy for cancer treatment.